Kyung Dong Pharmaceutical Co. Ltd - Asset Resilience Ratio
Kyung Dong Pharmaceutical Co. Ltd (011040) has an Asset Resilience Ratio of 4.72% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 011040 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2025)
This chart shows how Kyung Dong Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. See 011040 net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Kyung Dong Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Kyung Dong Pharmaceutical Co. Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩15.19 Billion | 4.72% |
| Total Liquid Assets | ₩15.19 Billion | 4.72% |
Asset Resilience Insights
- Limited Liquidity: Kyung Dong Pharmaceutical Co. Ltd maintains only 4.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Kyung Dong Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Kyung Dong Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Komipharm International Co. Ltd
KQ:041960 |
Pharmaceuticals | 2.23% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
ST Pharm Co.Ltd
KQ:237690 |
Pharmaceuticals | 7.72% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 61.00% |
|
Caregen Co.Ltd
KQ:214370 |
Pharmaceuticals | 4.58% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Mezzion Pharma Co.Ltd
KQ:140410 |
Pharmaceuticals | 13.09% |
|
Huons Global Co. Ltd
KQ:084110 |
Pharmaceuticals | 5.46% |
Annual Asset Resilience Ratio for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
The table below shows the annual Asset Resilience Ratio data for Kyung Dong Pharmaceutical Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.72% | ₩15.19 Billion ≈ $10.29 Million |
₩321.90 Billion ≈ $218.14 Million |
-5.49pp |
| 2024-12-31 | 10.21% | ₩30.91 Billion ≈ $20.95 Million |
₩302.87 Billion ≈ $205.25 Million |
-0.74pp |
| 2023-12-31 | 10.95% | ₩32.07 Billion ≈ $21.74 Million |
₩292.97 Billion ≈ $198.54 Million |
-3.59pp |
| 2022-12-31 | 14.53% | ₩45.13 Billion ≈ $30.58 Million |
₩310.48 Billion ≈ $210.41 Million |
-2.61pp |
| 2021-12-31 | 17.14% | ₩50.04 Billion ≈ $33.91 Million |
₩291.97 Billion ≈ $197.87 Million |
-3.91pp |
| 2020-12-31 | 21.05% | ₩61.34 Billion ≈ $41.57 Million |
₩291.39 Billion ≈ $197.47 Million |
-5.41pp |
| 2019-12-31 | 26.46% | ₩76.09 Billion ≈ $51.56 Million |
₩287.59 Billion ≈ $194.90 Million |
-1.41pp |
| 2018-12-31 | 27.87% | ₩71.85 Billion ≈ $48.69 Million |
₩257.79 Billion ≈ $174.70 Million |
+6.14pp |
| 2017-12-31 | 21.74% | ₩54.65 Billion ≈ $37.03 Million |
₩251.43 Billion ≈ $170.39 Million |
-6.57pp |
| 2016-12-31 | 28.31% | ₩67.51 Billion ≈ $45.75 Million |
₩238.49 Billion ≈ $161.62 Million |
+15.70pp |
| 2015-12-31 | 12.61% | ₩29.43 Billion ≈ $19.94 Million |
₩233.41 Billion ≈ $158.18 Million |
-3.63pp |
| 2014-12-31 | 16.24% | ₩36.98 Billion ≈ $25.06 Million |
₩227.68 Billion ≈ $154.30 Million |
-5.99pp |
| 2013-12-31 | 22.24% | ₩44.56 Billion ≈ $30.20 Million |
₩200.39 Billion ≈ $135.80 Million |
-2.98pp |
| 2012-12-31 | 25.21% | ₩47.71 Billion ≈ $32.33 Million |
₩189.23 Billion ≈ $128.24 Million |
+3.30pp |
| 2011-12-31 | 21.91% | ₩40.69 Billion ≈ $27.57 Million |
₩185.72 Billion ≈ $125.86 Million |
-- |
About Kyung Dong Pharmaceutical Co. Ltd
Kyung Dong Pharmaceutical Co., Ltd. produces and sells specialized and general medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, ant… Read more